Optimizing antithrombotic therapy after coronary stent implantation in patients on chronic oral anticoagulation.

about

Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine.Dual antiplatelet therapy in the anticoagulated patient undergoing percutaneous coronary intervention risks, benefits, and unanswered questions.

P2860

Q30278548-F5BB9271-5C4C-4F56-AEF3-9B9643B5F7EB Q38261199-0F014A31-E8FE-490D-9717-972DC0EEACD2

P2860

Optimizing antithrombotic therapy after coronary stent implantation in patients on chronic oral anticoagulation.

Item

http://www.wikidata.org/entity/Q38176288

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Optimizing antithrombotic ther ...... chronic oral anticoagulation.

@en

type

Item

label

Optimizing antithrombotic ther ...... chronic oral anticoagulation.

@en

prefLabel

Optimizing antithrombotic ther ...... chronic oral anticoagulation.

@en

P1476

Optimizing antithrombotic ther ...... chronic oral anticoagulation.

@en

P2093

D Sprenkeler

http://www.w3.org/2001/XMLSchema#string

J M ten Berg

http://www.w3.org/2001/XMLSchema#string

K Qaderdan

http://www.w3.org/2001/XMLSchema#string

N Bennaghmouch

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Warfarin, aspirin, or both after myocardial infarction

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA)

P2888

s12265-013-9536-2

P304

64-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12265-013-9536-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259608018

http://www.w3.org/2001/XMLSchema#string

P6179

1028700253

http://www.w3.org/2001/XMLSchema#string

P698

24395496

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

Optimizing antithrombotic therapy after coronary stent implantation in patients on chronic oral anticoagulation.

about

P2860

P2860

Optimizing antithrombotic therapy after coronary stent implantation in patients on chronic oral anticoagulation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P6179

P698

P921